Cargando…

A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL

CD19-directed chimeric antigen receptor (CAR) T cells have yielded impressive response rates in refractory/relapse B cell acute lymphoblastic leukemia (B-ALL); however, most patients ultimately relapse due to poor CAR T cell persistence or resistance of either CD19(+) or CD19(−) B-ALL clones. CD22 i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zanetti, Samanta Romina, Velasco-Hernandez, Talia, Gutierrez-Agüera, Francisco, Díaz, Víctor M., Romecín, Paola Alejandra, Roca-Ho, Heleia, Sánchez-Martínez, Diego, Tirado, Néstor, Baroni, Matteo Libero, Petazzi, Paolo, Torres-Ruiz, Raúl, Molina, Oscar, Bataller, Alex, Fuster, José Luis, Ballerini, Paola, Juan, Manel, Jeremias, Irmela, Bueno, Clara, Menéndez, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821938/ https://www.ncbi.nlm.nih.gov/pubmed/34478871 http://dx.doi.org/10.1016/j.ymthe.2021.08.033

Ejemplares similares

Enforced sialyl‐Lewis‐X (sLeX) display in E‐selectin ligands by exofucosylation is dispensable for CD19‐CAR T‐cell activity and bone marrow homing
por: Sánchez‐Martínez, Diego, et al.
Publicado: (2021)

Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope
por: Velasco-Hernandez, Talia, et al.
Publicado: (2020)

41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo
por: Baroni, Matteo Libero, et al.
Publicado: (2020)

Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity
por: Zanetti, Samanta Romina, et al.
Publicado: (2020)

Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia
por: Sánchez Martínez, Diego, et al.
Publicado: (2022)

CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
por: Bueno, Clara, et al.
Publicado: (2019)

TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia
por: Bueno, Clara, et al.
Publicado: (2023)

The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia
por: Lopez-Millan, Belen, et al.
Publicado: (2022)

CD34(+)CD19(−)CD22(+) B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies
por: Bueno, Clara, et al.
Publicado: (2022)

P1356: CD84-TARGETED CART-CELL THERAPY: A NOVEL STRATEGY FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES
por: Pérez Amill, Lorenza, et al.
Publicado: (2023)

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
por: Lopez-Millan, Belen, et al.
Publicado: (2019)

A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
por: Kellner, Markus, et al.
Publicado: (2022)

The insecticides permethrin and chlorpyrifos show limited genotoxicity and no leukemogenic potential in human and murine hematopoietic stem progenitor cells
por: Rodriguez-Cortez, Virginia C., et al.
Publicado: (2021)

Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells
por: Petazzi, Paolo, et al.
Publicado: (2020)

Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers
por: Blanco, Belén, et al.
Publicado: (2022)

SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells
por: Tahk, Siret, et al.
Publicado: (2021)

A Benchmark Side-by-Side Comparison of Two Well-Established Protocols for in vitro Hematopoietic Differentiation From Human Pluripotent Stem Cells
por: Gutierrez-Agüera, Francisco, et al.
Publicado: (2021)

Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
por: Tripaldi, Romina, et al.
Publicado: (2021)

Engraftment characterization of risk-stratified AML in NSGS mice
por: Díaz de la Guardia, Rafael, et al.
Publicado: (2021)

Senescent CD4(+)CD28(−) T Lymphocytes as a Potential Driver of Th17/Treg Imbalance and Alveolar Bone Resorption during Periodontitis
por: González-Osuna, Luis, et al.
Publicado: (2022)

Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice
por: Höfig, Ines, et al.
Publicado: (2012)

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30(+) lymphoma
por: Zhang, Peiling, et al.
Publicado: (2022)

The synthesis of CdZnTe semiconductor thin films for tandem solar cells
por: Shah, Nazar Abbas, et al.
Publicado: (2021)

Presentation of the Same Glycolipid by Different CD1 Molecules
por: Shamshiev, A., et al.
Publicado: (2002)

Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
por: Mi, Haoyang, et al.
Publicado: (2020)

Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients
por: Qu, Changju, et al.
Publicado: (2022)

Tandem Quadruplication of HMA4 in the Zinc (Zn) and Cadmium (Cd) Hyperaccumulator Noccaea caerulescens
por: Ó Lochlainn, Seosamh, et al.
Publicado: (2011)

Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity
por: Diskin, Ron, et al.
Publicado: (2010)

A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines
por: Schneider, Dina, et al.
Publicado: (2017)

Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
por: Alberti, Gaia, et al.
Publicado: (2023)

Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
por: Sahlberg, Sara Häggblad, et al.
Publicado: (2014)

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers
por: Jiménez-Reinoso, Anaïs, et al.
Publicado: (2022)

Interferon lambda 4 can directly activate human CD19(+) B cells and CD8(+) T cells
por: Coto-Llerena, Mairene, et al.
Publicado: (2020)

The density and spatial tissue distribution of CD8(+) and CD163(+) immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors
por: Massi, Daniela, et al.
Publicado: (2019)

A reporter system for enriching CRISPR/Cas9 knockout cells in technically challenging settings like patient models
por: Liu, Wen-Hsin, et al.
Publicado: (2021)

Engineering the Spin–Flip Limited Exciton Dephasing in Colloidal CdSe/CdS Quantum Dots
por: Accanto, Nicolò, et al.
Publicado: (2012)

Phenotype, Localization, and Mechanism of Suppression of CD4(+)CD25(+) Human Thymocytes
por: Annunziato, Francesco, et al.
Publicado: (2002)

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?
por: Liu, Sining, et al.
Publicado: (2023)

Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events
por: Serrano-Villar, Sergio, et al.
Publicado: (2022)

Pancreatic autoantibodies and CD14(+)CD16(+) monocytes subset are associated with the impairment of ß-cell function after simultaneous pancreas-kidney transplantation
por: Rodelo-Haad, Cristian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jse5ka2eqvrrar4ghc7i85tim1